Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Assets
Cash and due from banks	$ 27,165	$ 25,321
Interest earning deposits with banks	154,985	571,232
Cash and cash equivalents	182,150	596,553
Investment securities available for sale, at fair value	9,366	13,351
Investment securities held to maturity (fair value of $7,805 at December 31, 2022 and $10,025 at December 31, 2021)	9,378	9,918
Total investment securities	18,744	23,269
Loans, net of unearned income	1,751,459	1,484,847
Less: Allowance for loan losses	(31,845)	(29,845)
Net loans	1,719,614	1,455,002
Accrued interest receivable	8,768	7,681
Premises and equipment, net	5,958	6,265
Restricted stock	5,439	5,144
Bank owned life insurance (BOLI)	28,145	27,577
Deferred tax asset	9,184	7,608
Other	6,913	7,346
Total Assets	1,984,915	2,136,445
Deposits
Noninterest-bearing deposits	352,546	553,810
Interest-bearing deposits	1,223,435	1,214,600
Total deposits	1,575,981	1,768,410
FHLBNY borrowings	83,150	78,150
Subordinated debentures	42,921	42,732
Accrued interest payable	2,664	1,603
Accrued expenses and other liabilities	14,165	13,189
Total liabilities	1,718,881	1,904,084
Shareholders' Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 445 shares and 445 shares outstanding at December 31, 2022 and 2021, respectively	445	445
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,225,097 shares and 12,182,081 shares at December 31, 2022 and 2021, respectively	1,223	1,218
Additional paid-in capital	136,201	135,451
Retained earnings	131,706	98,017
Accumulated other comprehensive (loss) income	(526)	245
Treasury stock, 284,522 shares at December 31, 2022 and 2021, at cost	(3,015)	(3,015)
Accumulated other comprehensive income	266,034	232,361
Total liabilities and shareholders' equity	$ 1,984,915	$ 2,136,445